Genelux Corp (GNLX) — 10-Q Filings
All 10-Q filings from Genelux Corp. Browse 6 Quarterly Report reports with AI-powered summaries and risk analysis.
10-Q Filings (6)
-
GENELUX's Losses Widen Amid Increased R&D, Cash Dwindles
— Nov 5, 2025 Risk: high
GENELUX Corp reported a net loss of $22.9 million for the nine months ended September 30, 2025, an increase from $20.9 million for the same period in 2024. The -
GENELUX Remains Pre-Revenue, Focuses on Clinical Pipeline
— Aug 7, 2025 Risk: high
GENELUX Corp (GNLX) reported no revenue for the three and six months ended June 30, 2025, consistent with the prior year periods, as the company remains in the - 10-Q Filing — May 6, 2025
-
GENELUX Corp Files Q3 2024 10-Q
— Nov 14, 2024 Risk: low
GENELUX Corp filed its 10-Q for the period ending September 30, 2024. The company, incorporated in Delaware and operating in the Pharmaceutical Preparations sec -
GENELUX Corp Files Q2 2024 10-Q
— Aug 14, 2024 Risk: low
GENELUX Corp filed its 10-Q for the period ending June 30, 2024. The company, operating in the Pharmaceutical Preparations sector, is based in Westlake Village, -
GENELUX Corp Files 10-Q for Period Ending March 31, 2024
— May 9, 2024 Risk: low
GENELUX Corp (GNLX) filed a Quarterly Report (10-Q) with the SEC on May 9, 2024. GENELUX Corp filed a 10-Q report for the quarterly period ended March 31, 2024.
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX